点击“查看在招职位”，即表示您知悉并同意您的个人信息将被跨境传输至 Pivotal 总部（位于香港特别行政区），详细信息请查阅《招聘隐私政策》
深厚的行业资源和丰富的投资经验，使我们成为全球科学家和企业家的理想合作伙伴
Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China
Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund
Arctic Vision Announces US$32MN in Series A
Oncologie（鼎航医药）公布最新临床研究数据
Evommune完成1250万美元种子轮融资
OncXerna is selected as Global Top 5 Precision Medicine Startups
Exscientia announces investment of up to $525M
极目生物低浓度阿托品儿童近视疗法ARVN002三期临床试验申请获批，创新微量给药技术助力近视防控
Engrail Therapeutics Extends Series A Financing to $64 Million
极目生物脉络膜上腔注射疗法ARVN001获东盟十国及印度独家权益
Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China
Pivotal bioVenture Partners China Closes Inaugural $150 Million Early Stage VC Fund
Arctic Vision Announces US$32MN in Series A
Oncologie（鼎航医药）公布最新临床研究数据
Evommune完成1250万美元种子轮融资
OncXerna is selected as Global Top 5 Precision Medicine Startups
Exscientia announces investment of up to $525M
极目生物低浓度阿托品儿童近视疗法ARVN002三期临床试验申请获批，创新微量给药技术助力近视防控
Engrail Therapeutics Extends Series A Financing to $64 Million
极目生物脉络膜上腔注射疗法ARVN001获东盟十国及印度独家权益
上海
上海市长宁区紫云西路99号
艺丰中心2001室
200051，中国
香港
九龙启德协调道2号
AIRSIDE17层
中国香港特别行政区
旧金山
501 2nd Street, Suite 200
San Francisco, CA 94107
United States
中文
English
